The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

Silvia Pieralice,1 Rocco Amendolara,1 Valentina Berna,1 Giuseppina Manganaro,2 Annalisa Zurru,1 Luca D’Onofrio,1 Renata Risi,1 Marianna Alfonsi,1 Ernesto Maddaloni,1 Raffaella Buzzetti1 1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy; 2Vita- Salute San Raffaele Univers...

Descripción completa

Detalles Bibliográficos

Autores principales:	Pieralice S, Amendolara R, Berna V, Manganaro G, Zurru A, D'Onofrio L, Risi R, Alfonsi M, Maddaloni E, Buzzetti R
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2025-07-01
Colección:	Diabetes, Metabolic Syndrome and Obesity
Materias:	non-alcoholic fatty liver disease MASLD non-alcoholic steatohepatitis MASH Type 2 diabetes anti-hyperglycemic agents
Acceso en línea:	https://www.dovepress.com/the-emerging-role-of-anti-hyperglycemic-agents-for-the-management-of-m-peer-reviewed-fulltext-article-DMSO
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!